SM20 20mg*10vials

Semaglutide SM20 20mg*10vials

Semaglutide is a GLP-1 receptor agonist peptide that mimics the body's natural incretin hormone, representing a high-concentration metabolic research compound.

The 20mg single-vial specification delivers double the active ingredient content of the standard 10mg. This formulation is ideal for long-term metabolic studies, high-dose gradient experiments, and researchers conducting extended large-animal research. The higher concentration per vial significantly reduces the number of vials needed for prolonged experiments, minimizing handling variables and operational errors from repeated dilution.

Through GLP-1 receptor activation, this compound supports in-depth research into insulin secretion regulation, glycemic control pathways, appetite-related signaling, and metabolic homeostasis. It serves as a core research tool for investigating gut hormone effects on systemic metabolism and body weight regulation.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for long-term preclinical research and high-intensity laboratory projects.